Pharma Mar | PHM - Equity Capital And Reserves


Pharma Mar reported EUR197.51M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Alaunos Therapeutics USD 2.8M 858K Sep/2025
Almirall EUR 1.46B 25.28M Jun/2025
Avita Medical AUD -12.89M 17.39M Jun/2025
Dianthus Therapeutics USD 546.45M 243.38M Sep/2025
Ionis Pharmaceuticals USD 617.97M 13.76M Sep/2025
IQVIA Holdings USD 6.16B 382M Sep/2025
Laboratorios Farma EUR 539.39M 22.74M Dec/2023
Moderna USD 9.33B 69M Sep/2025
Organon & Co USD 906M 173M Sep/2025
Pharma Mar EUR 197.51M 4.02M Sep/2025
Revvity USD 7.38B 180.27M Sep/2025
Tectonic Therapeutic USD 267.53M 16.24M Sep/2025
Viatris USD 15.22B 352.9M Sep/2025
Xeris Pharmaceuticals USD -861K 18.44M Sep/2025